Toronto Star

Legal haze looms for drivers who use cannabis

Drugged driving laws, devices could criminaliz­e people who aren’t really impaired, critics say

- JENNIFER YANG STAFF REPORTER

For the millions of Canadians who use cannabis, there are just 64 days left until they can light up a joint, inhale and breathe easy knowing that they are staying comfortabl­y within the confines of the law.

But even after Oct. 17, when cannabis becomes legal, marijuana users who get behind the wheel will find themselves veering back into murky territory. While there may be new drugged driving laws on the books — and saliva testing devices heading soon to a police cruiser near you — critics say the legal landscape is still hazy for marijuana users who drive, with the potential to criminaliz­e people who are not actually impaired. Canadian regulators have now introduced legal limits for blood concentrat­ions of THC, the main psychoacti­ve compound in marijuana — even though researcher­s say there is no direct relationsh­ip between impairment and specific levels of THC in the bloodstrea­m. Critics have also pointed to potential issues with roadside saliva testing devices, which were not designed with Canadian winters in mind and require internal temperatur­es of at least 4 C to work.

Civil liberties advocates now worry the government has adopted a “zero tolerance” approach based on inconclusi­ve science.

They fear that sober people will end up receiving criminal records — and those at greatest risk will be medical cannabis users and racialized communitie­s that are already over-policed, said Rob De Luca with the Canadian Civil Liberties Associatio­n (CCLA).

“It’s going to criminaliz­e a host of individual­s who are basically going about their day, thinking they’re doing completely legal behaviour,” said De Luca, director of the CCLA’s public safety program. “The impact of bringing the full weight of the state and the criminal justice system against someone who may not have been impaired behind the wheel — that’s a remarkable thing.”

Critics such as De Luca do not question the dangers of drugimpair­ed driving or the importance of taking public safety into account. Studies have shown that cannabis can negatively impact cognitive and psychomoto­r performanc­e and organizati­ons like Mothers Against Drunk Driving have come out strongly in support of Canada’s new impaired driving laws.

Studies have also shown a higher risk of car crashes after cannabis use, with some papers suggesting a near-doubling of the risk. A recent Statistics Canada survey also found that one in seven cannabis users with a driver’s licence admitted to getting behind the wheel within two hours of consuming the drug.

But regulating cannabis is a much trickier propositio­n than regulating alcohol, which has now been thoroughly studied for decades. Alcohol is a simple molecule that eliminates from the body at a constant rate; cannabinoi­ds such as THC have complicate­d metabolic pathways and get stored in fat, releasing at different rates.

Frequent, chronic users — such as medical cannabis users — can also develop tolerance. And they can test THC positive for much longer periods than occasional smokers; one U.S. study, which looked at 30 men who were daily cannabis smokers, found that two people were still THC-positive 30 days after their last toke, albeit at low blood concentrat­ions.

There is plenty of evidence that a person with a blood alcohol concentrat­ion of more than 0.08, Canada’s legal limit, is clearly impaired. But cut-off points are harder to generalize for cannabis users because THC affects everyone so differentl­y, depending on a variety of factors — everything from a person’s history of cannabis use to the amount of fat tissue they have in their bodies.

“It makes it very complex to evaluate what a blood concentrat­ion means in terms of someone’s performanc­e or behaviour,” said Dayong Lee, a toxicology manager with the Houston Forensic Science Center who has studied cannabis and impairment.

But Canadian regulators have decided to impose blood concentrat­ion limits for THC, even while acknowledg­ing that “science is unable to provide general guidance to drivers about how much cannabis should be consumed before it is unsafe to drive or before the proposed levels would be exceeded.”

It is now illegal for Canadian drivers to have blood THC concentrat­ions of five nanograms (ng) per millilitre or more — a crime that carries mandatory penalties of $1,000 and jail time for repeat offenders. Drivers with at least 2.5 ng/ml of THC in their blood, combined with low levels of alcohol, will also be charged.

Regulators have also made it a summary offence to have concentrat­ions of between two and five nanograms per millilitre of blood. Offenders receive a maximum fine of $1,000 and a criminal record, which they can apply to suspend only after five years.

“The government should take every public safety approach that’s appropriat­e, but they shouldn’t take it when the scientific foundation is not clear,” said Kyla Lee, a Vancouver lawyer who defends impaired driving cases. “Meanwhile, people (will be) getting criminal records for drugs, which will render them inadmissib­le to the United States and have all sorts of consequenc­es for employment, families, life insurance, etc.”

According to Dayong Lee, the cut-off points of two and five nanograms per millilitre are based on a handful of studies in which the majority of people showed some cognitive impairment at these concentrat­ions. But these studies are based on relatively small population­s and “it’s hard to generalize” their results, she said.

“I can think of less than 10 studies that support the five nanograms being impaired,” Lee said. “It’s really critical that drug blood concentrat­ion itself is not being used solely to demonstrat­e that this person is impaired.”

Forensic toxicologi­st Marilyn Huestis agrees. During her two decades with the U.S. National Institute on Drug Abuse, she conducted numerous studies looking at cannabis impairment and was “amazed” to find that in one small study of chronic cannabis users, she could still detect signs of impairment even three weeks after their last usage.

But she has yet to see a significan­t correlatio­n between specific blood drug concentrat­ions and impairment. “My philosophy for identifyin­g impaired driving ... the first thing is that you show the person is really impaired. Because some people might have five (nanograms) or two (nanograms) and maybe they’re not impaired,” she said. “Then you do the biological sample to point (out) which drugs are causing the impairment.”

Yet, Canadian laws do not explicitly require drivers get tested for impairment before they can be charged with drug-impaired driving.

The Canadian government is also introducin­g new roadside devices that act as a kind of breathalyz­er exam for drugs, including THC. But instead of blowing, drivers provide saliva samples that are tested on the spot using the same immunologi­cal technology as pregnancy sticks.

These devices can reveal whether specific drugs might be present, but further tests are needed to confirm blood concentrat­ion levels. The first device being considered for Canadian approval is the Draeger DrugTest 5000, which has received early criticism for requiring an internal temperatur­e of at least 4 C. “Lots of Canada, lots of the time, is below four degrees Celsius,” Kyla Lee said.

In an email, Draeger Canada said its technology is “well suited to Canada, with internal temperatur­e control functional­ity that helps ensure optimal performanc­e in a broad range of conditions” but was unable to respond to followup questions by press time.

Huestis said she’s tested the Draeger DrugTest 5000 and it “works very well.” The device is already in use in countries such as Australia and Spain, and in Norway, police apprehensi­ons of DUI drivers more than doubled after the device was introduced, according to a 2018 study.

But other jurisdicti­ons have reported lacklustre experience­s with the device. According to tender documents, the Irish government anticipate­d that 50,000 tests would be performed with the device every year. Last year, however, police only used it on 612 drivers, with 90 testing positive for drug use.

A senior police officer told the Irish Times that the length of time required to use the device — at least 10 minutes — was a deterrent for officers, who opted to focus on alcohol detection instead. He said some officers struggled to get usable saliva samples from nervous drivers, whose mouths would dry up.

According to a federal Department of Justice spokespers­on, the Draeger DrugTest 5000 was recommende­d for approval by the Canadian Society of Forensic Science, which is also evaluating a number of other drug screeners. The device is now undergoing a 30-day “public comment period” that closes on Aug. 18, after which the attorney general will decide whether or not to approve it for use in Canada.

 ?? MARTIN MEISSNER/THE ASSOCIATED PRESS ?? The first drug-screening device being considered for Canadian approval is the Draeger DrugTest 5000.
MARTIN MEISSNER/THE ASSOCIATED PRESS The first drug-screening device being considered for Canadian approval is the Draeger DrugTest 5000.

Newspapers in English

Newspapers from Canada